HSP90AA1 and Parkinson disease: Furthermore, this work supports the hypothesis that enhancement of Hsp90 levels through Hsp90 inducers (8,9), positive allosteric modulators of Hsp90 (7,10), or Hsp90 inhibitors that activate the heat shock response (7) could be a therapeutic strategy for conditions characterized by protein aggregation, such as AD and PD.